Migraine Relief
- Manufacturer
- Apotheca Company
- Effective date
- 2011-06-28
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:03:14
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS: Belladonna 10X, Bryonia 10X, Cyclamen europaeum 8X, Gelsemium sempervirens 6X, Sanguinaria canadensis 8X, Spigelia anthelmia 8X.
OTC - PURPOSE SECTION
USES: Migraine Headache pain relief
WARNINGS SECTION
WARNINGS:
If pregnant or breast-feeding, ask a health professional before use.
Stop use and ask a doctor if symptoms continue or get worse, or new symptoms appear
Keep our of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Do not use if safety seal around cap is broken or missing.
DOSAGE & ADMINISTRATION SECTION
DIRECTIONS: Adults and children 12 or over take 2 caps at first onset of symptoms, then take 2 caps every 3-4 hours as needed. Results are usually felt within an hour and improve with continued use. If symptoms are frequent, try 1-2 caps twice daily to reduce/prevent symptoms.
INACTIVE INGREDIENT SECTION
INACTIVE INGREDIENTS: Microcrystalline cellulose, Vegetable capsule (cellulose). Herbal blend - Chinese licorice root, Chinese lovage root, Chinese mint herb, Chinese skullcap root, Corydalis yanhusuo root, Costus root, Dong quai root, Fragrant angelica root, Gastrodia root, Ginger root, Gypsum calcined, Heal all herb, Magnolia flower, Poria fungal body, Siler root, Simple-leaf chaste tree fruit, Tangerine peel, Uncaria rhynchophylla stem.
Capsule Size: '00'. Contains no animal products, corn, gluten, soy, wheat, or yeast.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center right away.
INDICATIONS & USAGE SECTION
USES: Migraine Headache pain
OTC - QUESTIONS SECTION
Manufactured for:
RidgeCrest Herbals, Inc.
3683 West 2270 South, Suite A
Salt Lake City, UT 84120-2306
1-800-242-4649
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Migraine Relief
NEW VEGAN FORMULA
Homeopathic Remedy With Herbal Support
RIDGECREST HERBALS
60 VEG CAPSULES
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57520-0423-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-d982-f424-e053-dadaa90a57ce | Migraine Relief |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57520-0423-1 | Migraine Relief | 60 in 1 BOTTLE | CAPSULE | 60 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 57520-0423 | MIGRAINE RELIEF (BELLADONNA, BRYONIA, CYCLAMEN EUROPAEUM, GELSEMIUM SEMPERVIRENS, SANGUIANARIA CANADENSIS, SPIGELIA ANTHELMIA) CAPSULE [APOTHECA COMPANY] | 1 | Legacy NDC, 1 package rows | 20110629_a8a4449a-4e1f-4334-bc5b-2e0c82ac2592.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ATROPA BELLADONNA | ACTIVE INGREDIENT | WQZ3G9PF0H | 1 | |
| BRYONIA ALBA ROOT | ACTIVE INGREDIENT | T7J046YI2B | 1 | |
| CYCLAMEN PURPURASCENS TUBER | ACTIVE INGREDIENT | G728143D8Q | 1 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE INGREDIENT | 639KR60Q1Q | 1 | |
| SANGUINARIA CANADENSIS ROOT | ACTIVE INGREDIENT | N9288CD508 | 1 | |
| SPIGELIA ANTHELMIA | ACTIVE INGREDIENT | WYT05213GE | 1 | |
| ATROPA BELLADONNA | ACTIVE MOIETY | WQZ3G9PF0H | 1 | |
| BRYONIA ALBA ROOT | ACTIVE MOIETY | T7J046YI2B | 1 | |
| CYCLAMEN PURPURASCENS TUBER | ACTIVE MOIETY | G728143D8Q | 1 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE MOIETY | 639KR60Q1Q | 1 | |
| SANGUINARIA CANADENSIS ROOT | ACTIVE MOIETY | N9288CD508 | 1 | |
| SPIGELIA ANTHELMIA | ACTIVE MOIETY | WYT05213GE | 1 | |
| ANGELICA DAHURICA ROOT | INACTIVE INGREDIENT | 1V63N2S972 | 1 | |
| ANGELICA SINENSIS ROOT | INACTIVE INGREDIENT | B66F4574UG | 1 | |
| CALCIUM SULFATE HEMIHYDRATE | INACTIVE INGREDIENT | 3RW091J48V | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| CORYDALIS YANHUSUO TUBER | INACTIVE INGREDIENT | 0TUP42692Z | 1 | |
| COSTUS ROOT OIL | INACTIVE INGREDIENT | 2WF6750061 | 1 | |
| FU LING | INACTIVE INGREDIENT | XH37TWY5O4 | 1 | |
| GASTRODIA ELATA TUBER | INACTIVE INGREDIENT | 08F85I5YAV | 1 | |
| GINGER | INACTIVE INGREDIENT | C5529G5JPQ | 1 | |
| GLYCYRRHIZA URALENSIS | INACTIVE INGREDIENT | 42B5YD8F0K | 1 | |
| LIGUSTICUM SINENSE ROOT | INACTIVE INGREDIENT | 32SLT970XO | 1 | |
| MAGNOLIA OFFICINALIS FLOWER | INACTIVE INGREDIENT | KO528PK8VZ | 1 | |
| MENTHA ARVENSIS FLOWERING TOP | INACTIVE INGREDIENT | 807G27ZYZ0 | 1 | |
| PRUNELLA VULGARIS FLOWERING TOP | INACTIVE INGREDIENT | ID3IB81B1C | 1 | |
| SAPOSHNIKOVIA DIVARICATA ROOT | INACTIVE INGREDIENT | 8H84LFK2QD | 1 | |
| SCUTELLARIA BAICALENSIS ROOT | INACTIVE INGREDIENT | 7J95K7ID2S | 1 | |
| TANGERINE PEEL | INACTIVE INGREDIENT | JU3D414057 | 1 | |
| UNCARIA RHYNCHOPHYLLA STEM | INACTIVE INGREDIENT | 1XCM98TE9T | 1 | |
| VITEX TRIFOLIA FRUIT | INACTIVE INGREDIENT | Q04E1F5351 | 1 |
Products#
Every source-derived product name is available through these pages.
- Migraine Relief
- Belladonna, Bryonia, Cyclamen europaeum, Gelsemium sempervirens, Sanguianaria canadensis, Spigelia anthelmia
- ATROPA BELLADONNA
- BRYONIA ALBA ROOT
- CYCLAMEN PURPURASCENS TUBER
- GELSEMIUM SEMPERVIRENS ROOT
- SANGUINARIA CANADENSIS ROOT
- SPIGELIA ANTHELMIA
- GLYCYRRHIZA URALENSIS
- LIGUSTICUM SINENSE ROOT
- MENTHA ARVENSIS FLOWERING TOP
- SCUTELLARIA BAICALENSIS ROOT
- CORYDALIS YANHUSUO TUBER
- COSTUS ROOT OIL
- ANGELICA SINENSIS ROOT
- ANGELICA DAHURICA ROOT
- GASTRODIA ELATA TUBER
- GINGER
- PRUNELLA VULGARIS FLOWERING TOP
- MAGNOLIA OFFICINALIS FLOWER
- CELLULOSE, MICROCRYSTALLINE
- FU LING
- SAPOSHNIKOVIA DIVARICATA ROOT
- VITEX TRIFOLIA FRUIT
- TANGERINE PEEL
- UNCARIA RHYNCHOPHYLLA STEM
- CALCIUM SULFATE HEMIHYDRATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 57520-0423 | 57520-0423-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE / ORAL | 1725 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, FOR SUSPENSION / ORAL | 278 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE / ORAL | 29520 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING / ORAL | 1800 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IMPLANT / INTRAVITREAL | 1.66 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 144 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SUSPENSION / ORAL | 4441 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 580 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, DELAYED RELEASE / ORAL | 366 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / BUCCAL | 18 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | PELLET / ORAL | 1140 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | SUSPENSION / ORAL | 1600 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE / ORAL | 2169 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FOR SUSPENSION / ORAL | 20100 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / SUBLINGUAL | 43.2 mg | ||
| GINGER | GINGER | C5529G5JPQ | ELIXIR / ORAL | 10 mg/5ml | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, EXTENDED RELEASE / ORAL | 1246 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, DELAYED RELEASE / ORAL | 789.6 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | SUSPENSION, EXTENDED RELEASE / ORAL | 1120 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 1576 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, EXTENDED RELEASE / ORAL | 5119 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE / ORAL | 2210 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 615 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SOLUTION / ORAL | 690 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TROCHE / ORAL | 300 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| GINGER | GINGER | C5529G5JPQ | SYRUP / ORAL | 0.05 ml/5ml | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, COATED PELLETS / ORAL | 456 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f15a4fae-b01a-4016-8fe2-f99517e61ff5 | a8a4449a-4e1f-4334-bc5b-2e0c82ac2592 | 2011-06-28 | Warnings | f15a4fae-b01a-4016-8fe2-f99517e61ff5 a8a4449a-4e1f-4334-bc5b-2e0c82ac2592 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
